insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 $
arrow_downward
-4,09%(-0,070) 1D
1,64 $
0,00% (0,00)
bedtimeAfter hours
Closed: 20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
1,75 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
1,75 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 Top Movers: Today's Biggest Gainers and Losers
marketscreener.com
·
14 րոպե առաջ
S&P 500, Dow Slide Into Correction Territory as Investors Seek Treasury Cover Amid Big-Tech Plunge
Investing.com
·
38 րոպե առաջ
S&P 500 Rebound Could Be Coming as ETF Selling Nears Capitulation
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc